On the upside
Angiotech Pharmaceuticals (Nasdaq: ANPI) announced positive results from a clinical trial by its partner Boston Scientific (NYSE: BSX) for the platimun chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System.
Citigroup analyst Deborah Weinswig upgraded Wal-Mart (NYSE: WMT) to a Buy rating and lifted her price target on the retailer.
General Electric (NYSE: GE) will sell its energy business GE Energy to Babcock & Wilcox Power Generation Group.
On the downside
Gray Television (NYSE: GTN) warned that it may breach its financial covenants at the end of the month.
Thor Industries (NYSE: THO) announced the appointment of J. Allen Kosowsky to the Boad of Directors.
Fourth quarter earnings for Sterling Construction (Nasdaq: STRL) tumbled to fall far short of estimates.
